525 related articles for article (PubMed ID: 33604555)
1. Cross-platform comparison of highly sensitive immunoassay technologies for cytokine markers: Platform performance in post-traumatic stress disorder and Parkinson's disease.
Lasseter HC; Provost AC; Chaby LE; Daskalakis NP; Haas M; Jeromin A
Cytokine X; 2020 Jun; 2(2):100027. PubMed ID: 33604555
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of highly sensitive immunoassay technologies for quantitative measurements of sub-pg/mL levels of cytokines in human serum.
Yeung D; Ciotti S; Purushothama S; Gharakhani E; Kuesters G; Schlain B; Shen C; Donaldson D; Mikulskis A
J Immunol Methods; 2016 Oct; 437():53-63. PubMed ID: 27555238
[TBL] [Abstract][Full Text] [Related]
3. How to: Measuring blood cytokines in biological psychiatry using commercially available multiplex immunoassays.
Belzeaux R; Lefebvre MN; Lazzari A; Le Carpentier T; Consoloni JL; Zendjidjian X; Abbar M; Courtet P; Naudin J; Boucraut J; Gressens P; Glaichenhaus N; Ibrahim EC
Psychoneuroendocrinology; 2017 Jan; 75():72-82. PubMed ID: 27810706
[TBL] [Abstract][Full Text] [Related]
4. A comparison of biofluid cytokine markers across platform technologies: Correspondence or divergence?
Casaletto KB; Elahi FM; Fitch R; Walters S; Fox E; Staffaroni AM; Bettcher BM; Zetterberg H; Karydas A; Rojas JC; Boxer AL; Kramer JH
Cytokine; 2018 Nov; 111():481-489. PubMed ID: 29908923
[TBL] [Abstract][Full Text] [Related]
5. Cytokine Profiling in Plasma from Patients with Brain Tumors Versus Healthy Individuals using 2 Different Multiplex Immunoassay Platforms.
Bender DE; Schaettler MO; Sheehan KC; Johanns TM; Dunn GP
Biomark Insights; 2021; 16():11772719211006666. PubMed ID: 33854293
[TBL] [Abstract][Full Text] [Related]
6. Measurement of IL-21 in human serum and plasma using ultrasensitive MSD S-PLEX® and Quanterix SiMoA methodologies.
Poorbaugh J; Samanta T; Bright SW; Sissons SE; Chang CY; Oberoi P; MacDonald AJ; Martin AP; Cox KL; Benschop RJ
J Immunol Methods; 2019 Mar; 466():9-16. PubMed ID: 30590020
[TBL] [Abstract][Full Text] [Related]
7. Comparison of multiplex platforms for cytokine assessments and their potential use for biomarker profiling in multiple sclerosis.
Malekzadeh A; Twaalfhoven H; Wijnstok NJ; Killestein J; Blankenstein MA; Teunissen CE
Cytokine; 2017 Mar; 91():145-152. PubMed ID: 28082233
[TBL] [Abstract][Full Text] [Related]
8. Hyaluronidase treatment of synovial fluid to improve assay precision for biomarker research using multiplex immunoassay platforms.
Jayadev C; Rout R; Price A; Hulley P; Mahoney D
J Immunol Methods; 2012 Dec; 386(1-2):22-30. PubMed ID: 22955210
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Bead-Based Fluorescence Versus Planar Electrochemiluminescence Multiplex Immunoassays for Measuring Cytokines in Human Plasma.
Günther A; Becker M; Göpfert J; Joos T; Schneiderhan-Marra N
Front Immunol; 2020; 11():572634. PubMed ID: 33101295
[TBL] [Abstract][Full Text] [Related]
10. Correlation of XMAP and ELISA cytokine profiles; development and validation for immunotoxicological studies in vitro.
Codorean E; Nichita C; Albulescu L; Răducan E; Popescu ID; Lonită AC; Albulescu R
Roum Arch Microbiol Immunol; 2010; 69(1):13-9. PubMed ID: 21053779
[TBL] [Abstract][Full Text] [Related]
11. Performance evaluation of three platforms with ultrasensitive ligand-binding assay potential.
Cowan KJ; Geiger A; Hornauer H; Rourick R; Siguenza PY
Bioanalysis; 2017 Jun; 9(12):937-946. PubMed ID: 28627218
[TBL] [Abstract][Full Text] [Related]
12. Development of a bead-based multiplex assay to quantify bovine interleukin-10, tumor necrosis factor-α, and interferon-γ concentrations in plasma and cell culture supernatant.
Sipka A; Mann S; Babasyan S; Freer H; Wagner B
JDS Commun; 2022 May; 3(3):207-211. PubMed ID: 36338808
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Different Platform Immunoassays for the Measurement of Plasma Alpha-Synuclein in Parkinson's Disease Patients.
Youssef P; Kim WS; Halliday GM; Lewis SJG; Dzamko N
J Parkinsons Dis; 2021; 11(4):1761-1772. PubMed ID: 34151860
[TBL] [Abstract][Full Text] [Related]
14. Bladder cancer risk stratification with the Oncuria 10-plex bead-based urinalysis assay using three different Luminex xMAP instrumentation platforms.
Furuya H; Sakatani T; Tanaka S; Murakami K; Waldron RT; Hogrefe W; Rosser CJ
J Transl Med; 2024 Jan; 22(1):8. PubMed ID: 38167321
[TBL] [Abstract][Full Text] [Related]
15. Comparison of ophthalmic sponges and extraction buffers for quantifying cytokine profiles in tears using Luminex technology.
Inic-Kanada A; Nussbaumer A; Montanaro J; Belij S; Schlacher S; Stein E; Bintner N; Merio M; Zlabinger GJ; Barisani-Asenbauer T
Mol Vis; 2012; 18():2717-25. PubMed ID: 23233782
[TBL] [Abstract][Full Text] [Related]
16. Optimization of a bovine cytokine multiplex assay using a new bovine and cross-reactive equine monoclonal antibodies.
Sipka A; Babasyan S; Asbie S; Freer H; Wagner B
Vet Immunol Immunopathol; 2024 Jul; 273():110789. PubMed ID: 38820946
[TBL] [Abstract][Full Text] [Related]
17. Fast and Efficient Measurement of Clinical and Biological Samples Using Immunoassay-Based Multiplexing Systems.
Zhang Y; Li X; Di YP
Methods Mol Biol; 2020; 2102():129-147. PubMed ID: 31989552
[TBL] [Abstract][Full Text] [Related]
18. Development of a bead-based multiplex assay for the simultaneous detection of porcine inflammation markers using xMAP technology.
Bongoni AK; Lanz J; Rieben R; Banz Y
Cytometry A; 2013 Jul; 83(7):636-47. PubMed ID: 23576245
[TBL] [Abstract][Full Text] [Related]
19. Validation of a multiplex electrochemiluminescent immunoassay platform in human and mouse samples.
Bastarache JA; Koyama T; Wickersham NE; Ware LB
J Immunol Methods; 2014 Jun; 408():13-23. PubMed ID: 24768796
[TBL] [Abstract][Full Text] [Related]
20. Comparative Analysis of Multiple Immunoassays for Cytokine Profiling in Drug Discovery.
Platchek M; Lu Q; Tran H; Xie W
SLAS Discov; 2020 Dec; 25(10):1197-1213. PubMed ID: 32924773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
